The relevance of this enzyme in melanoma was further confirmed by our analysis of the SKCM patient cohort of TCGA that showed that high transcript levels of DUOX1 were associated with poor survival of early-stage but not of late-stage SKCM patients. The gene discussed is DUOX1; the disease is melanoma.